T-cell acute lymphoblastic leukemia with natural killer cell phenotype

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous lymphoid malignancy.
• Understanding the specific cell lineage of ALL is crucial for accurate diagnosis and treatment.
• Natural Killer (NK) cells are a type of lymphocyte with cytotoxic functions.

Purpose of the Study:

• To identify the prevalence and characteristics of acute lymphoblastic leukemia (ALL) cases exhibiting a natural killer (NK) cell phenotype.
• To investigate the potential origin of T-cell ALL from NK cell malignancies.

Main Methods:

• Analysis of leukemic blasts from 31 children with ALL (14 T-ALL, 17 non-T-ALL).
• Detection of NK-specific antigens using monoclonal antibodies (Leu 11b, Leu 7, 1G2).
• Assessment of cytotoxic activity (spontaneous and antibody-dependent) and cell morphology (L2).

Main Results:

• No T-ALL blasts expressed Leu 11b antigen.
• Four T-ALL patients had blasts positive for 1G2 and/or Leu 7 antigens.
• These four patients exhibited varying degrees of NK cell-like cytotoxic activity and L2 morphology.

Conclusions:

• A notable proportion of T-cell acute lymphoblastic leukemias may represent malignancies of NK cell origin.
• NK cell phenotype in T-ALL warrants further investigation for diagnostic and therapeutic implications.
• This finding could refine the classification of acute lymphoblastic leukemia subtypes.